Publication | Open Access

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

HepatologyNonalcoholic Fatty Liver DiseaseMedicineLiver PhysiologyOne-year ResultsNonalcoholic SteatohepatitisHepatotoxicityPharmacotherapyRosiglitazone TherapyLiver DiseaseFatty Liver DiseasePharmacologyHealth Sciences